Efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with ribavirin for the treatment of HCV genotype 1b compensated cirrhosis in patients aged 70 years or older.
Trifan A, Stanciu C, Gheorghe L, Iacob S, Curescu M, Cijevschi Prelipcean C, Stefanescu G, Girleanu I, Chiriac S, Mihai C, Brisc C, Goldis A, Sporea I, Miftode E, Bataga S, Rogoveanu I, Preda C, Caruntu FA, Singeap AM.
Trifan A, et al. Among authors: chiriac s.
Medicine (Baltimore). 2017 Dec;96(50):e9271. doi: 10.1097/MD.0000000000009271.
Medicine (Baltimore). 2017.
PMID: 29390377
Free PMC article.